ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2022 and some content may be unavailable. To unlock all content for 2022, please visit the archives.

Abstract: FR-PO276

Cilk1 Deficiency Induces Cyst Formation and Abnormal Ciliary Trafficking via Klc3

Session Information

Category: Genetic Diseases of the Kidneys

  • 1101 Genetic Diseases of the Kidneys: Cystic

Authors

  • Ko, Je Yeong, Sookmyung Women's University, Yongsan-gu, Seoul , Korea (the Republic of)
  • Rah, Gyuyeong, Sookmyung Women's University, Yongsan-gu, Seoul , Korea (the Republic of)
  • Park, Jong Hoon, Sookmyung Women's University, Yongsan-gu, Seoul , Korea (the Republic of)
Background

Ciliogenesis-associated kinase 1 (CILK1), also known as intestinal cell kinase (ICK), is localized in the basal bodies of cilia and regulates ciliary transport. Mutations in the CILK1 gene induces various ciliopathies, including endocrine-cerebro-osteodysplasia syndrome and juvenile myoclonic epilepsy; however, the mechanism underlying the ciliary defect in the CILK1-deficient kidney has not been elucidated.

Methods

We generated mice with specific deletion of Cilk1 in renal collecting duct and performed yeast-two-hybrid assay to identify a novel ciliary regulator in Cilk1-deficient model.

Results

CILK1 deficiency results in polycystic kidney disease (PKD) and abnormal ciliary trafficking in cyst lining cells. We identified a novel ciliary regulator, kinesin light chain 3 (KLC3), which promotes ciliary trafficking and cyst progression in CILK1 deficient PKD. KLC3 overexpression induced ciliary recruitment of IFT-B and EGFR, which contributed to the ciliary defect involved in cyst progression. Reduction in KLC3 restored abnormal ciliary trafficking and inhibited cyst progression caused by CILK1 deficiency, indicating that KLC3 is a ciliary regulator related to cyst progression in CILK1 deficient PKD.

Conclusion

We found that CILK1 deficiency leads to PKD accompanied by abnormal ciliary trafficking via KLC3 overexpression. These results provide new insight into the pathogensis of CILK1 deficient PKD model.

Funding

  • Government Support – Non-U.S.